Stoke Therapeutics Inc — Balance Sheet (NASDAQ:STOK) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 297.93 M238.87 M256.07 M228.34 M271.56 M Total liabilities 11.85 M21.09 M71.22 M68.78 M42.53 M Total equity 286.08 M217.78 M184.85 M159.56 M229.02 M Total liabilities & shareholders' equities 297.93 M238.87 M256.07 M228.34 M271.56 M Total debt ————— Net debt —————

뉴스

These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.

This Rare Disease Biotech Name Teases Around A Buy Point

A Pair Of AI Stocks Lead 5 Top Performers Onto Best Stock Screens

스토크 테라퓨틱스, 구겐하임 ’매수’ 의견 제시 후 주가 급등

Stoke Therapeutics stock jumps after Guggenheim initiates with Buy rating

구겐하임, Stoke Therapeutics에 ’매수’ 등급 제시...드라벳 증후군 치료제 주목

Stoke Therapeutics: FDA Delay Doesn't Change Zorevunersen's Opportunity (NASDAQ:STOK)

Stoke Therapeutics, Inc. (STOK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:STOK) 2026-01-13

일라이릴리 경쟁 속에서도 바이오젠 주식 전망은 긍정적, RBC ’아웃퍼폼’ 등급 유지

Gold Miner Franco-Nevada Hits Record High, Leads 12 Hot Growth Stocks Onto Best Stock Lists

스토크 테라퓨틱스, Cantor Fitzgerald ’비중확대’ 등급 유지

Stoke Therapeutics stock maintains Overweight rating at Cantor Fitzgerald